Prim, S.A. (5P1.F)
- Previous Close
10.55 - Open
10.60 - Bid 10.70 x --
- Ask 11.00 x --
- Day's Range
10.60 - 10.60 - 52 Week Range
9.16 - 11.60 - Volume
90 - Avg. Volume
6 - Market Cap (intraday)
183.745M - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
16.56 - EPS (TTM)
0.64 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 0.22 (2.09%)
- Ex-Dividend Date Mar 11, 2025
- 1y Target Est
--
Prim, S.A. provides health technology, mobility, and health care products in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, ORTHOPrim, PRIMcare, respira PLUS, airMed, airtex, AirTex breathable, aqtivo skin, aqtivo sport, comforGel, comforGel Lady, comforSil, ESSENCIAL, mottio sport range, my PRIM Kids, Neoprair, ONE SIZE, Primespine, and OLIUM brand names. It operates PrimAcademy, an offline and digital training platform. The company was founded in 1870 and is headquartered in Móstoles, Spain.
www.prim.esRecent News: 5P1.F
View MorePerformance Overview: 5P1.F
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is IBEX 35... (^IBEX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5P1.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5P1.F
View MoreValuation Measures
Market Cap
182.88M
Enterprise Value
187.63M
Trailing P/E
16.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.77
Price/Book (mrq)
1.39
Enterprise Value/Revenue
0.80
Enterprise Value/EBITDA
7.15
Financial Highlights
Profitability and Income Statement
Profit Margin
4.68%
Return on Assets (ttm)
4.48%
Return on Equity (ttm)
8.57%
Revenue (ttm)
233.36M
Net Income Avi to Common (ttm)
10.92M
Diluted EPS (ttm)
0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
14.16M
Total Debt/Equity (mrq)
14.35%
Levered Free Cash Flow (ttm)
11.86M